Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Mandel

Showing results (41-50 of 219) with videos related to

Pageof 22
Sort By:
The Journal of Urology|March 2, 2016
Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical ProstatectomyKatharina Boehm, Alessandro Larcher, Zhe Tian, et al.
World Journal of Urology|January 14, 2016
Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomyBurkhard Beyer, Philipp Mandel, Uwe Michl, et al.
Hormones & Cancer|March 2, 2017
Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell CarcinomaMaximilian Christian Kriegmair, Philipp Mandel, Stefan Porubsky, et al.
Clinical Genitourinary Cancer|September 6, 2016
Defining Renal Masses: Comprehensive Comparison of RENAL, PADUA, NePhRO, and C-Index ScoreMaximilian C Kriegmair, Philipp Mandel, Anett Moses, et al.
Cancers|September 28, 2023
Intermittent Radioligand Therapy with <sup>177</sup>Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate CancerNicolai Mader, Christina Schoeler, Niloufar Pezeshkpour, et al.
World Journal of Urology|April 3, 2019
Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of ageDerya Tilki, Valentin Maurer, Raisa S Pompe, et al.
World Journal of Urology|August 23, 2017
Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatmentPhilipp Mandel, Clemens Rosenbaum, Raisa S Pompe, et al.
The Prostate|November 22, 2021
Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancerFelix Preisser, Christoph Würnschimmel, Randi M Pose, et al.
European Urology Open Science|June 17, 2025
Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate CancerMike Wenzel, Thomas Steuber, Carolin Siech, et al.
Urologic Oncology|December 17, 2017
Effect of repeat prostate biopsies on functional outcomes after radical prostatectomyClemens M Rosenbaum, Philipp Mandel, Pierre Tennstedt, et al.
Pageof 22

Showing results (41-50 of 219) with videos related to

Sort By:
Pageof 22
The Journal of Urology|March 2, 2016
Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical ProstatectomyKatharina Boehm, Alessandro Larcher, Zhe Tian, et al.
World Journal of Urology|January 14, 2016
Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomyBurkhard Beyer, Philipp Mandel, Uwe Michl, et al.
Hormones & Cancer|March 2, 2017
Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell CarcinomaMaximilian Christian Kriegmair, Philipp Mandel, Stefan Porubsky, et al.
Clinical Genitourinary Cancer|September 6, 2016
Defining Renal Masses: Comprehensive Comparison of RENAL, PADUA, NePhRO, and C-Index ScoreMaximilian C Kriegmair, Philipp Mandel, Anett Moses, et al.
Cancers|September 28, 2023
Intermittent Radioligand Therapy with <sup>177</sup>Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate CancerNicolai Mader, Christina Schoeler, Niloufar Pezeshkpour, et al.
World Journal of Urology|April 3, 2019
Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of ageDerya Tilki, Valentin Maurer, Raisa S Pompe, et al.
World Journal of Urology|August 23, 2017
Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatmentPhilipp Mandel, Clemens Rosenbaum, Raisa S Pompe, et al.
The Prostate|November 22, 2021
Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancerFelix Preisser, Christoph Würnschimmel, Randi M Pose, et al.
European Urology Open Science|June 17, 2025
Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate CancerMike Wenzel, Thomas Steuber, Carolin Siech, et al.
Urologic Oncology|December 17, 2017
Effect of repeat prostate biopsies on functional outcomes after radical prostatectomyClemens M Rosenbaum, Philipp Mandel, Pierre Tennstedt, et al.
Pageof 22